Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Ramirez

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Experimental Neurology|April 29, 2008
Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neuronsKathie M Bishop, Eva K Hofer, Arpesh Mehta, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2005
Regulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neuronsArmin Blesch, James Conner, Alexander Pfeifer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Striatal delivery of neurturin by CERE-120, an AAV2 vector for the treatment of dopaminergic neuron degeneration in Parkinson's diseaseMehdi Gasmi, Christopher D Herzog, Eugene P Brandon, et al.
Experimental Neurology|November 18, 2008
Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene deliveryAlan H Nagahara, Tim Bernot, Rod Moseanko, et al.
Neurobiology of Aging|September 26, 2008
Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normalLiana G Apostolova, Lisa Mosconi, Paul M Thompson, et al.
The Journal of Clinical Investigation|February 4, 2009
Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stressMichael I Dorrell, Edith Aguilar, Ruth Jacobson, et al.
Pediatric Nephrology (Berlin, Germany)|June 4, 2013
Vitamin D bioavailability and catabolism in pediatric chronic kidney diseaseMichelle R Denburg, Heidi J Kalkwarf, Ian H de Boer, et al.
Iscience|August 23, 2024
The role of brown adipose tissue in branched-chain amino acid clearance in peopleYasser G Abdelhafez, Guobao Wang, Siqi Li, et al.
Archives of Cardiovascular Diseases|March 15, 2024
The real incidence of sudden death: Fair estimations or futile speculations?Nathan Marimpouy, Céline Guilbeau-Frugier, Jean Ferrières, et al.
European Heart Journal Open|October 29, 2025
Current causes of sudden death in large populations: differences between resuscitated patients and autopsied casesNathan Marimpouy, Céline Guilbeau-Frugier, Anthony Ramirez, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Experimental Neurology|April 29, 2008
Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neuronsKathie M Bishop, Eva K Hofer, Arpesh Mehta, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2005
Regulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neuronsArmin Blesch, James Conner, Alexander Pfeifer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Striatal delivery of neurturin by CERE-120, an AAV2 vector for the treatment of dopaminergic neuron degeneration in Parkinson's diseaseMehdi Gasmi, Christopher D Herzog, Eugene P Brandon, et al.
Experimental Neurology|November 18, 2008
Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene deliveryAlan H Nagahara, Tim Bernot, Rod Moseanko, et al.
Neurobiology of Aging|September 26, 2008
Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normalLiana G Apostolova, Lisa Mosconi, Paul M Thompson, et al.
The Journal of Clinical Investigation|February 4, 2009
Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stressMichael I Dorrell, Edith Aguilar, Ruth Jacobson, et al.
Pediatric Nephrology (Berlin, Germany)|June 4, 2013
Vitamin D bioavailability and catabolism in pediatric chronic kidney diseaseMichelle R Denburg, Heidi J Kalkwarf, Ian H de Boer, et al.
Iscience|August 23, 2024
The role of brown adipose tissue in branched-chain amino acid clearance in peopleYasser G Abdelhafez, Guobao Wang, Siqi Li, et al.
Archives of Cardiovascular Diseases|March 15, 2024
The real incidence of sudden death: Fair estimations or futile speculations?Nathan Marimpouy, Céline Guilbeau-Frugier, Jean Ferrières, et al.
European Heart Journal Open|October 29, 2025
Current causes of sudden death in large populations: differences between resuscitated patients and autopsied casesNathan Marimpouy, Céline Guilbeau-Frugier, Anthony Ramirez, et al.
Pageof 2